Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible

Shiksha Kedia1, Gwenalyn Garcia1, Meekoo Dhar1

  • 1Department of Hematology and Oncology, Staten Island University Hospital.

Cureus
|February 3, 2016
PubMed